TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

The purpose of this research study is to see if Near-Infrared Tomographic Optical Breast Imaging (TOBI) scans can help monitor breast tumor response during treatment for breast cancer. The images created by the TOBI scan show changes in blood blow and oxygen levels in breast tissue.

Key facts

Study ID

NCT00783757

Run by

Steven Isakoff, MD, PhD

People needed

30

Starts

2008-08-01

Expected to finish

2017-06-01

Last updated by the study team

2017-07-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Adult female patients presenting to the MGH Cancer Center Gillette Center for breast cancer neoadjuvant therapy
• Subject who have had or will have a clinically indicated pre-treatment breast MRI

You may not qualify if…

• Younger than 18 years of age
• Open wounds on breast
• Breast implants, because they may interfere with readings
• Subjects who will be receiving preoperative therapy for <28 days
• Breast surgery or biopsy < 10 days prior to optical imaging scan
• Medical or psychiatric or other medical condition that the principal investigator believes may result in inability to complete the study
• Bilateral breast cancers or a history of contralateral breast cancer

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.